A Clinical Study of Manahshiladi Lepa in Psoriasis

Abstract

Skin is the largest organ of the body which protects the body from the outer environment. It is the organ that reflects many internal diseases by changing its character. Psoriasis is an autoimmune papulosquamous disorder that represents an inflammation pattern of the skin to various stimuli. It is characterized by sharply demarcated erythematous plaque/patches/papules covered with silvery scaling. Psoriasis is a common dermatological problem affecting up to 2.5% of the world population. While various researches have been made in the field of Medical Science, but still there is no absolute, simple, safe and invariably effective permanent cure of Psoriasis has been attained till today. The aim is to evaluate the effect of Manahshiladi lepa in Psoriasis. We had registered 21 patients randomly for the trial with Manahshiladi lepa in OPD, Department of Kaya Chikitsa, S.A.C. Lucknow. Period of study was March 2007 to May 2008. Results showed that after four months of treatment with Manahshiladi lepa 15 patients (71.43%) were relieved, five patients (12.8%) were improved and one patient (4.76%) remained unchanged. It was concluded that Manahshiladi lepa is safe, effective and economical for the patients of Psoriasis. No side effects have been observed during the trial.